Locations
Washington, DC, USA · Washington, DC, USA · Connecticut Ave/ K Street, Washington, DC, USA · Fort Stanton, Washington, DC, USA
Size
1 - 10 employees
Stage
Series B
founded in
2017
Chase Therapeutics is an early-stage, product-based specialty pharmaceutical company focused on the development of better treatments for neuropsychiatric diseases. The company is pioneering the discovery and development of best-in-class or first-to-market pharmaceuticals, emphasizing the rapid translation of therapeutic breakthroughs in neuroscience research to prevent and cure brain dysfunction. With a unique approach to drug development, Chase Therapeutics aims to address significant unmet needs in the market, positioning itself as a leader in the specialty pharmaceutical sector.
Something looks off?